Structured evidence table for Taurine Muscle Soreness Randomized Trial, generated from 3 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Taurine Muscle Soreness Randomized Trial | As life expectancy increases, age-associated declines in muscle strength, metabolic flexibility, immune responsiveness, and cognitive resilience have become major contributors to morbidity and diminished quality of life. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Muscle Soreness Randomized Trial | Despite these benefits, the biological response to exercise is often dampened in aging due to reduced mitochondrial efficiency, lower anabolic sensitivity, impaired antioxidant capacity, and chronic inflammatory signaling. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Muscle Soreness Randomized Trial | As a result, older adults commonly experience delayed recovery, attenuated gains in muscle strength or aerobic capacity, and limited adaptations compared with younger individuals. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Muscle Soreness Randomized Trial | Kirkwood, 2005 Lutz and Quinn, 2012 Falahi et al., 2025 Liang et al., 2022 Hébert, 1997 The steady growth of the global older population has intensified scientific attention toward biological processes that erode functional capacity and compromise independence with aging. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Muscle Soreness Randomized Trial | In general, high force eccentric contractions and/or unaccustomed exercise result in DOMS attributed to reduction in performance such as muscle strength and range of motion (ROM) for both athletes and non-athletes. | 3 | Kim J (2014) | A review of nutritional intervention on delayed onset muscle soreness. Part I. |
| Taurine Muscle Soreness Randomized Trial | This review is focused on the effect of nutritional intervention on delayed onset muscle soreness (DOMS) that occurs after exercise. | 3 | Kim J (2014) | A review of nutritional intervention on delayed onset muscle soreness. Part I. |
| Taurine Muscle Soreness Randomized Trial | Conclusion A combination of 3.2 g BCAA and 2.0 g taurine, three times a day, for two weeks prior to and three days after exercise may be a useful nutritional strategy for attenuating exercise-induced DOMS and muscle damage. | 4 | Ra SG (2013) | Combined effect of branched-chain amino acids and taurine supplementation on delayed onset muscle soreness and muscle damage in high-intensity eccentric exercise. |
| Taurine Muscle Soreness Randomized Trial | Background Previous studies have evaluated the effectiveness of branched-chain amino acid (BCAA) supplementation for preventing delayed onset muscle soreness (DOMS) and muscle damage induced by eccentric exercise, their findings have been inconclusive. | 4 | Ra SG (2013) | Combined effect of branched-chain amino acids and taurine supplementation on delayed onset muscle soreness and muscle damage in high-intensity eccentric exercise. |
| Taurine Muscle Soreness Randomized Trial | Since taurine has anti-inflammatory and anti-oxidative effects, the present study investigated the combined effect of BCAA and taurine on DOMS and muscle damage. | 4 | Ra SG (2013) | Combined effect of branched-chain amino acids and taurine supplementation on delayed onset muscle soreness and muscle damage in high-intensity eccentric exercise. |
Source documents